Search

everythinglearnresearchcommunity

for

Search:↓

The document explains how certain drugs block hormones to treat cancers like breast and prostate cancer.

Finasteride effectively treats enlarged prostate and male baldness, improves symptoms of hirsutism in women, but doesn't work for acne, and may delay prostate cancer progression with few side effects.

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.

PAK4 is crucial in cancer progression, brain development, and could be a therapeutic target, especially through the PAK4-CREB axis.

Myricetin shows promise as an anticancer agent by reducing inflammation and enhancing drug effectiveness.

A new compound was effective for imaging prostate cancer in rats.

Scientists at the University of Michigan Medical School successfully created a special compound that can be used to improve imaging of prostate cancer.

Swedish men with the E213 A-allele of the androgen receptor have a lower risk of prostate cancer.

5α-reductase inhibitors may prevent prostate cancer but could also raise the risk of more severe cancers.

Doxil showed some effectiveness against advanced prostate cancer but caused severe side effects at higher doses.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Certain genetic variants increase the risk of resistance to hormone therapy in prostate cancer patients.

In 2007, prostate cancer research improved understanding of risk, diagnosis, and treatment, but also showed heart risks with certain therapies and the need for personalized care.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

Prostate cancer prevention includes diet changes, supplements, and medications, with more answers expected soon.

Baldness at age 40 is not linked to a higher risk of aggressive prostate cancer.

Hair loss gene linked to prostate issues.

Extracellular vesicles and androgen receptors may help identify prostate cancer resistance and reduce SARS-CoV-2 infection.

Higher cholesterol levels increase aggressive prostate cancer risk.

TGFβ's manipulation of inflammation and immune cells affects cancer spread, suggesting new treatment strategies and biomarkers.

Finasteride might lower the risk of low-grade prostate cancer but not high-grade cancer, while alpha-blockers might reduce high-grade cancer risk.

Men who experienced baldness at age 20 may have double the risk of getting prostate cancer.

Suppressing certain hormones might help prevent prostate cancer.

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.

A young man with high-grade prostate cancer had successful surgery and good recovery, highlighting the need for awareness in younger men.

Eating more omega-3 and less omega-6 fatty acids may lower the risk of developing prostate cancer.

Steroid sex hormones activate matriptase in prostate cancer cells but not in breast cancer cells.